These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

400 related items for PubMed ID: 19186196

  • 1. Rough mutants defective in core and O-polysaccharide synthesis and export induce antibodies reacting in an indirect ELISA with smooth lipopolysaccharide and are less effective than Rev 1 vaccine against Brucella melitensis infection of sheep.
    Barrio MB, Grilló MJ, Muñoz PM, Jacques I, González D, de Miguel MJ, Marín CM, Barberán M, Letesson JJ, Gorvel JP, Moriyón I, Blasco JM, Zygmunt MS.
    Vaccine; 2009 Mar 10; 27(11):1741-9. PubMed ID: 19186196
    [Abstract] [Full Text] [Related]

  • 2. Development and evaluation as vaccines in mice of Brucella melitensis Rev.1 single and double deletion mutants of the bp26 and omp31 genes coding for antigens of diagnostic significance in ovine brucellosis.
    Cloeckaert A, Jacques I, Grilló MJ, Marín CM, Grayon M, Blasco JM, Verger JM.
    Vaccine; 2004 Jul 29; 22(21-22):2827-35. PubMed ID: 15246618
    [Abstract] [Full Text] [Related]

  • 3. Immunological responses and protective efficacy against Brucella melitensis induced by bp26 and omp31 B. melitensis Rev.1 deletion mutants in sheep.
    Jacques I, Verger JM, Laroucau K, Grayon M, Vizcaino N, Peix A, Cortade F, Carreras F, Guilloteau LA.
    Vaccine; 2007 Jan 15; 25(5):794-805. PubMed ID: 17070627
    [Abstract] [Full Text] [Related]

  • 4. Antibody response and antigen-specific gamma-interferon profiles of vaccinated and unvaccinated pregnant sheep experimentally infected with Brucella melitensis.
    Durán-Ferrer M, Léon L, Nielsen K, Caporale V, Mendoza J, Osuna A, Perales A, Smith P, De-Frutos C, Gómez-Martín B, Lucas A, Chico R, Delgado OD, Escabias JC, Arrogante L, Díaz-Parra R, Garrido F.
    Vet Microbiol; 2004 Jun 03; 100(3-4):219-31. PubMed ID: 15145500
    [Abstract] [Full Text] [Related]

  • 5. Brucellosis vaccines: assessment of Brucella melitensis lipopolysaccharide rough mutants defective in core and O-polysaccharide synthesis and export.
    González D, Grilló MJ, De Miguel MJ, Ali T, Arce-Gorvel V, Delrue RM, Conde-Alvarez R, Muñoz P, López-Goñi I, Iriarte M, Marín CM, Weintraub A, Widmalm G, Zygmunt M, Letesson JJ, Gorvel JP, Blasco JM, Moriyón I.
    PLoS One; 2008 Jul 23; 3(7):e2760. PubMed ID: 18648644
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of bp26 and bp26/omp31 B. melitensis Rev.1 deletion mutants against Brucella ovis in rams.
    Grilló MJ, Marín CM, Barberán M, de Miguel MJ, Laroucau K, Jacques I, Blasco JM.
    Vaccine; 2009 Jan 07; 27(2):187-91. PubMed ID: 19007836
    [Abstract] [Full Text] [Related]

  • 7. Protection of BALB/c mice against homologous and heterologous species of Brucella by rough strain vaccines derived from Brucella melitensis and Brucella suis biovar 4.
    Winter AJ, Schurig GG, Boyle SM, Sriranganathan N, Bevins JS, Enright FM, Elzer PH, Kopec JD.
    Am J Vet Res; 1996 May 07; 57(5):677-83. PubMed ID: 8723881
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of Brucella melitensis Rev. 1 vaccine against Brucella ovis infection in rams.
    Fensterbank R, Pardon P, Marly J.
    Ann Rech Vet; 1982 May 07; 13(2):185-90. PubMed ID: 7168540
    [Abstract] [Full Text] [Related]

  • 9. Assessment of serological response of young and adult sheep to conjunctival vaccination with Rev-1 vaccine by fluorescence polarization assay (FPA) and other serological tests for B. melitensis.
    Stournara A, Minas A, Bourtzi-Chatzopoulou E, Stack J, Koptopoulos G, Petridou E, Sarris K.
    Vet Microbiol; 2007 Jan 17; 119(1):53-64. PubMed ID: 16973307
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of Brucella melitensis B115 as rough-phenotype vaccine against B. melitensis and B. ovis infections.
    Adone R, Francia M, Ciuchini F.
    Vaccine; 2008 Sep 08; 26(38):4913-7. PubMed ID: 18675869
    [Abstract] [Full Text] [Related]

  • 11. Use of recombinant BP26 protein in serological diagnosis of Brucella melitensis infection in sheep.
    Cloeckaert A, Baucheron S, Vizcaino N, Zygmunt MS.
    Clin Diagn Lab Immunol; 2001 Jul 08; 8(4):772-5. PubMed ID: 11427425
    [Abstract] [Full Text] [Related]

  • 12. Rough vaccines in animal brucellosis: structural and genetic basis and present status.
    Moriyón I, Grilló MJ, Monreal D, González D, Marín C, López-Goñi I, Mainar-Jaime RC, Moreno E, Blasco JM.
    Vet Res; 2004 Jul 08; 35(1):1-38. PubMed ID: 15099501
    [Abstract] [Full Text] [Related]

  • 13. Immunopathological responses and kinetics of Brucella melitensis Rev 1 infection after subcutaneous or conjunctival vaccination in rams.
    Muñoz PM, de Miguel MJ, Grilló MJ, Marín CM, Barberán M, Blasco JM.
    Vaccine; 2008 May 19; 26(21):2562-9. PubMed ID: 18423950
    [Abstract] [Full Text] [Related]

  • 14. [Persistence of serologic and allergic reactions in ewes after vaccination with the H.38 or Rev.1 vaccines in a brucellosis (Brucella melitensis) enzootic area].
    Pardon P, Sanchis R, Molenat G, Bouchard N, Schmitt D, Marly J, Durand M.
    Ann Rech Vet; 1989 May 19; 20(1):65-72. PubMed ID: 2930135
    [Abstract] [Full Text] [Related]

  • 15. Antibodies to the CP24 protein of Brucella melitensis lack diagnostic usefulness in ovine brucellosis.
    Delpino MV, Cassataro J, Fossati CA, Baldi PC.
    Vet Microbiol; 2003 May 19; 93(2):101-7. PubMed ID: 12636998
    [Abstract] [Full Text] [Related]

  • 16. Comparison of the efficacy of Brucella abortus strain RB51 and Brucella melitensis Rev. 1 live vaccines against experimental infection with Brucella melitensis in pregnant ewes.
    el Idrissi AH, Benkirane A, el Maadoudi M, Bouslikhane M, Berrada J, Zerouali A.
    Rev Sci Tech; 2001 Dec 19; 20(3):741-7. PubMed ID: 11732416
    [Abstract] [Full Text] [Related]

  • 17. B. melitensis rough strain B115 is protective against heterologous Brucella spp. infections.
    Adone R, Francia M, Pistoia C, Pesciaroli M, Pasquali P.
    Vaccine; 2011 Mar 21; 29(14):2523-9. PubMed ID: 21300102
    [Abstract] [Full Text] [Related]

  • 18. Residual virulence and immunogenicity of CGV26 and CGV2631 B. melitensis Rev. 1 deletion mutant strains in sheep after subcutaneous or conjunctival vaccination.
    Guilloteau LA, Laroucau K, Olivier M, Grillo MJ, Marin CM, Verger JM, Blasco JM.
    Vaccine; 2006 Apr 24; 24(17):3461-8. PubMed ID: 16519974
    [Abstract] [Full Text] [Related]

  • 19. Competitive enzyme-linked immunosorbent assay using monoclonal antibodies to the Brucella melitensis BP26 protein to evaluate antibody responses in infected and B. melitensis Rev.1 vaccinated sheep.
    Debbarh HS, Zygmunt MS, Dubray G, Cloeckaert A.
    Vet Microbiol; 1996 Dec 24; 53(3-4):325-37. PubMed ID: 9008343
    [Abstract] [Full Text] [Related]

  • 20. Brucella outer membrane complex-loaded microparticles as a vaccine against Brucella ovis in rams.
    Muñoz PM, Estevan M, Marín CM, Jesús De Miguel M, Jesús Grilló M, Barberán M, Irache JM, Blasco JM, Gamazo C.
    Vaccine; 2006 Mar 10; 24(11):1897-905. PubMed ID: 16337315
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.